Cargando…

Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease

BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Form...

Descripción completa

Detalles Bibliográficos
Autores principales: Verplaetse, Nora, Passemiers, Antoine, Arany, Adam, Moreau, Yves, Raimondi, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552306/
https://www.ncbi.nlm.nih.gov/pubmed/37798735
http://dx.doi.org/10.1186/s13059-023-03064-y
_version_ 1785115933499457536
author Verplaetse, Nora
Passemiers, Antoine
Arany, Adam
Moreau, Yves
Raimondi, Daniele
author_facet Verplaetse, Nora
Passemiers, Antoine
Arany, Adam
Moreau, Yves
Raimondi, Daniele
author_sort Verplaetse, Nora
collection PubMed
description BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Formula: see text] ). Millions of variants are present in each individual while the collection of large, homogeneous cohorts is hindered by phenotype incidence, sequencing cost, and batch effects. RESULTS: We demonstrate that when we provide enough training data and control the complexity of nonlinear models, a neural network outperforms additive approaches in whole exome sequencing-based inflammatory bowel disease case–control prediction. To do so, we propose a biologically meaningful sparsified neural network architecture, providing empirical evidence for positive and negative epistatic effects present in the inflammatory bowel disease pathogenesis. CONCLUSIONS: In this paper, we show that underdetermination is likely a major driver for the apparent optimality of additive modeling in clinical genetics today. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03064-y.
format Online
Article
Text
id pubmed-10552306
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105523062023-10-06 Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease Verplaetse, Nora Passemiers, Antoine Arany, Adam Moreau, Yves Raimondi, Daniele Genome Biol Research BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Formula: see text] ). Millions of variants are present in each individual while the collection of large, homogeneous cohorts is hindered by phenotype incidence, sequencing cost, and batch effects. RESULTS: We demonstrate that when we provide enough training data and control the complexity of nonlinear models, a neural network outperforms additive approaches in whole exome sequencing-based inflammatory bowel disease case–control prediction. To do so, we propose a biologically meaningful sparsified neural network architecture, providing empirical evidence for positive and negative epistatic effects present in the inflammatory bowel disease pathogenesis. CONCLUSIONS: In this paper, we show that underdetermination is likely a major driver for the apparent optimality of additive modeling in clinical genetics today. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03064-y. BioMed Central 2023-10-05 /pmc/articles/PMC10552306/ /pubmed/37798735 http://dx.doi.org/10.1186/s13059-023-03064-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Verplaetse, Nora
Passemiers, Antoine
Arany, Adam
Moreau, Yves
Raimondi, Daniele
Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title_full Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title_fullStr Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title_full_unstemmed Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title_short Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
title_sort large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552306/
https://www.ncbi.nlm.nih.gov/pubmed/37798735
http://dx.doi.org/10.1186/s13059-023-03064-y
work_keys_str_mv AT verplaetsenora largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease
AT passemiersantoine largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease
AT aranyadam largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease
AT moreauyves largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease
AT raimondidaniele largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease